Endeavour Vision accelerates investments in Switzerland and the US – an interview with AGEFI Endeavour Vision Founding Partners Damien Tappy and Bernard Vogel spoke to AGEFI about the next fund and the firm’s investment approach. Read the article from AGEFI here Medtech: Endeavour Vision accélère ses investissements en [...]
Relievant Announces Publication of Positive Results from Multi-Center Study of the Intracept® Procedure in Real-world Setting for Patients with Chronic Low Back Pain MINNEAPOLIS – August 27, 2019 – Relievant Medsystems, a privately-held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), today announced the [...]
V-Wave’s Interatrial Shunt Receives FDA Breakthrough Device Designation for Heart Failure CAESAREA, Israel, Aug. 15, 2019 — V-Wave Ltd., a privately held medical device company developing novel implantable interatrial shunt devices, today announced that the U.S. Food and Drug Administration (FDA) has just granted the company a Breakthrough Device [...]
Molecular Partners’ strategic partner Allergan announces that EMA has validated the marketing authorisation application for abicipar CAESAREA, Israel, Aug. 15, 2019 — V-Wave Ltd., a privately held medical device company developing novel implantable interatrial shunt devices, today announced that the U.S. Food and Drug Administration (FDA) has just granted [...]
Interview with Rob Barmann, Senior Investment Director at Endeavour Vision Previously Vice President, Corporate Business Development at Boston Scientific. Rob, you joined Endeavour Vision after 15 years working at Boston Scientific, can you summarise your role there? My job was to assess and execute business development transactions including acquisitions, [...]
Interview with Kevin Hykes, President & CEO at Relievant Can you tell us a bit about Relievant Medsystems and the Intracept® Procedure? Relievant is a venture-backed medical device company founded in 2006, based in Minneapolis and Sunnydale, California with around 45 employees. Our focus is currently shifting from [...]
CeQur appoints Bradley Paddock Chief Executive Officer Medical Device Veteran Has 23-Year Record of Successful Commercial and Organizational Leadership MARLBOROUGH, Mass., June 5, 2019 — CeQur® announced that the company has appointed Bradley Paddock as chief executive officer, effective today. Paddock brings a track record of commercial medtech successes, [...]
Interview with Chris Owens, CEO & President at Gynesonics, Inc What is Gynesonics about? How are you changing the standard of care in uterine fibroids? Gynesonics is focused on advancing women’s health by developing uterus-preserving, incision free, transcervical technology. Currently, we are focused on the treatment of symptomatic [...]
Boston Scientific Announces Agreement to Acquire Vertiflex, Inc. Acquisition of lumbar spinal stenosis treatment to expand portfolio of interventional pain therapies. Vertiflex has raised approximately $160 million in funding from investors including Endeavour Vision, NEA and H.I.G. BioVentures. MARLBOROUGH, Mass., May 9, 2019 / — Boston Scientific (NYSE: [...]
Nuvaira receives french innovation funding for Nuvaira Airflow-3 pivotal trail Acquisition of lumbar spinal stenosis treatment to expand portfolio of interventional pain therapies. Novel program provides reimbursement for TLD therapy in France MINNEAPOLIS, April 28, 2018 – Nuvaira, developer of novel therapeutic strategies to treat obstructive lung diseases, [...]